AOP Orphan Pharmaceuticals has announced the spin-off of its 80% stake in Activartis, a Vienna-based biotech company, to a group of private investors. Activartis has developed dendritic cell-based technology for individualized tumor ...
Tags: AOP Orphan, Medicine
Roche has announced that the Canadian Health Authority has approved the use of its PCR based mycoplasma detection test MycoTOOL for release testing of one of its biological products. Accepted by the FDA at the end of 2012, the test can ...
Tags: Roche, Health Authority
The US FDA has cleared Sanofi Pasteur's supplemental biologics license application (sBLA) licensing four-strain influenza vaccine, Fluzone Quadrivalent, for broad age range of children and adults. As the first and only four-strain ...
Tags: Influenza Vaccine, Medicine
GlaxoSmithKline (GSK) has acquired a Switzerland-based vaccines company, Okairos, for €250m in cash to boost its existing vaccine platform technology expertise and to continue developing the next generation of vaccines. Under the ...
Tags: Glaxosmithkline, Vaccines Business
Liquidia, the designer and manufacturer of engineered particles, has announced that its collaboration with PATH has been extended to develop next generation Pneumococcal vaccine. The vaccine, if successful, could potentially allow for ...
Tags: Liquidia, Pneumococcal Vaccine
Clinical stage biopharmaceutical company Soligenix has received US patent for the vaccine thermostabilization technology, ThermoVax. The patent claims describe methods of preparing an immunologically-active adjuvant-bound, thermostable, ...
Tags: Thermovax Technology, US Patent
ImmunoCellular Therapeutics has obtained US patent for methods of use of interleukin 13-receptor alpha 2 protein (IL-13Rα2) in cancer immunotherapy. IL-13 is an immune regulatory cytokine and IL-13Ra2 is highly and specifically ...
Tags: Immunocellular, US Patent, Alpha 2 Protein
The Indian government has announced the development of new low-cost vaccine referred to as Rotavac against rotavirus, a diarrhea causative agent leading to a number of childhood deaths in the developing world. The new rotavirus vaccine is ...
Tags: Vaccine, Diarrhea Virus
Newman Labelling Systems has supplied an S250 fully automatic labeling machine to the US-based Merck Animal Health. According to the pharmaceutical labeling systems supplier, Merck Animal Health will use the S250 to label poultry vaccine ...
Tags: Newman, Labeling Machine
The European Commission has approved Sanofi Pasteur's 6-in-1 pediatric vaccine Hexyon/Hexacima (DTaP-IPV-Hib-HepB vaccine) for primary and booster vaccination of infants from six weeks of age. The EC decision follows the European ...
Tags: Pediatric Vaccine, Medicine
H7N9 is a serotype of the species Influenzavirus A (avian influenza virus or bird flu virus). H7 normally circulates amongst avian populations with some variants known to occasionally infect humans. An H7N9 virus was first reported to have ...
VaxInnate, a US-based biotechnology firm, has received a grant from the National Institute of Allergy and Infectious Diseases (NIAID) to fund the development of a recombinant vaccine for the prevention of dengue. The grant will provide ...
GlaxoSmithKline (GSK) has received the marketing authorization from Germany's Paul Ehrlich Institut (PEI) and the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK for its quadrivalent (four-strain) influenza vaccine. ...
Tags: GSK, Strain Influenza Vaccine
Australia's $9 billion polymers industry will be boosted by a national cooperative research initiative. The launch featured a novel degradable plastic film that Greening Australia and the Birchip Cropping Group have shown can dramatically ...
Tags: Chemicals, plastic film, Packaging, Printing
Sirona Biochem has obtained a European patent for a new family of carbohydrate-based compounds. The compounds are related to Sirona's SGLT2 inhibitor and skin depigmenting agents are protected by the patent. TFChem, a subsidiary of ...
Tags: carbohydrate, carbohydrate chemistry, diabetes therapeutics